Key players in Pain Management Drugs
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 2 |  Johnson & Johnson |
jnj.com (opens in a new tab) | 2,376 reports |
| 3 | Haleon PLC | — | 330 reports |
| 4 |  Purdue Pharma |
purduepharma.com (opens in a new tab) | 66 reports |
| 5 | Vertex Pharmaceuticals | — | 264 reports |
Also active in Pain Management Drugs
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Hikma Pharmaceuticals PLC |
|
| Caplin | |
 Fresenius SE & CO |
|
| Somerset Theraps LLC | |
| Eugia Pharma | |
| Inforlife | |
| Gland | |
| Anthea Pharma | |
| Mylan N.V. | |
 Amneal Pharmaceuticals, Inc |
|
| Kindos | |
 Apotex Inc |
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Pain Management Drugs reports by place
One report for each place. Each tile opens that place's report.
Regions 7
Countries 26
Australia report
Brazil report
Canada report
China report
Ecuador report
Egypt report
France report
Germany report
Hong Kong report
India report
Italy report
Japan report
Kenya report
Malaysia report
Mexico report
New Zealand report
Philippines report
Russia report
Saudi Arabia report
Singapore report
South Africa report
Spain report
Thailand report
UAE report
UK report
US report
Compare all 33 places for Pain Management Drugs, with active trials
Get the full Pain Management Drugs report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.